Deep TMS News - Get The Latest News On BrainsWay's Deep TMS

News May 19, 2021

BrainsWay to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

CRESSKILL, N.J. and JERUSALEM, May 19, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

News May 6, 2021

BrainsWay to Report First Quarter 2021 Financial Results on May 20, 2021

CRESSKILL, N.J. and JERUSALEM, Israel, May 6, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

News May 5, 2021

BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer

CRESSKILL, N.J. and JERUSALEM, May 05, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

News May 4, 2021

BrainsWay Announces Social Media Sweepstakes to Celebrate Mental Health Awareness Month

The Sweepstakes, demonstrating how Deep Transcranial Magnetic Stimulation (Deep TMS) can fit into an...

News May 3, 2021

BrainsWay to Ring NASDAQ Closing Bell to Highlight May as Mental Health Awareness Month

CRESSKILL, N.J. and JERUSALEM, May 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

News April 29, 2021

BrainsWay Announces Launch of Noninvasive Treatment for Smoking Addiction to U.S. Providers

Patients in areas across the country now have access to Deep Transcranial Magnetic Stimulation (Deep...

News April 26, 2021

BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder

Shorter Protocol Further Expands Access to Care CRESSKILL, N.J. and JERUSALEM, April 26, 2021 (GLOBE...

News April 14, 2021

BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS)

The FDA cleared technology is a noninvasive treatment for depression, OCD, and smoking addiction CRESSKILL,...

News March 24, 2021

BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights

Conference call to be held tomorrow, March 25, 2021, at 8:30 AM ET CRESSKILL, N.J. and JERUSALEM, Israel,...

News March 11, 2021

BrainsWay to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

CRESSKILL, N.J., March 11, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...

News March 8, 2021

BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference

CRESSKILL, N.J. and JERUSALEM, Israel, March 8, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

News March 1, 2021

BrainsWay Ltd. Announces Closing of $45.2 Million Underwritten Public Offering of American Depositary Shares Including Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares

CRESSKILL, N.J. and JERUSALEM, Israel, March 1, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

News February 23, 2021

BrainsWay Ltd. Announces Pricing of $39,287,000 Underwritten Offering of American Depositary Shares

CRESSKILL, N.J. and JERUSALEM, Feb. 23, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

News February 22, 2021

BrainsWay Ltd. Announces Proposed Public Offering of American Depositary Shares

CRESSKILL, N.J. and JERUSALEM, Feb. 22, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

News February 16, 2021

BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales

CRESSKILL, N.J. and JERUSALEM, Israel, February 16, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...